Official Report of Meeting 19 April 2023
Written Submissions
PE1950/A: Chief Pharmaceutical Officer submission of 9 August 2022 (100.1KB, pdf)
PE1950/B: Blanche Hampton submission of 14 October 2022 (113.4KB, pdf)
PE1950/C: Scottish Medicines Consortium submission of 9 December 2022 (95.9KB, pdf)
PE1950/D: Immunodeficiency UK submission of 29 November 2022 (187.8KB, pdf)
PE1950/E: Blood Cancer UK submission of 16 December 2022 (146.3KB, pdf)
PE1950/F: Kidney Research UK submission of 5 January 2023 (139KB, pdf)
PE1950/G: Petitioner submission of 31 January 2023 (43.1KB, pdf).